An improvement of NAMPT protein and NAD levels by the bioflavonoid troxerutin or leucine was shown to protect mice with diet-induced obesity against steatosis, inflammation and glucose intolerance [13, 14] indicating an important role of NAMPT in the development of NAFLD. The gene discussed is NAMPT; the disease is obesity due to melanocortin 4 receptor deficiency.